PD
CSTL icon

Point72 (DIFC)’s Castle Biosciences CSTL Stock Holding History

Point72 (DIFC)’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$54.3K Buy
+2,386
New +$48.5K ﹤0.01% 708
2025
Q2 		– Sell
-1,773
Closed -$35.5K – 1658
2025
Q1 		$35.5K Buy
1,773
+539
+44% +$13.3K ﹤0.01% 1261
2024
Q4 		$32.9K Sell
1,234
-3,661
-75% -$111K ﹤0.01% 1188
2024
Q3 		$140K Buy
+4,895
New +$125K ﹤0.01% 916

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 (DIFC)'s CSTL Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in Castle Biosciences (CSTL) in Q3 2025: 2,386 shares worth $54.3K. The stake represents ﹤0.01% of the portfolio and ranks #708 among its holdings. This is a return to the name: Point72 (DIFC) previously reported a position in CSTL as recently as Q1 2025.

Point72 (DIFC) first reported a position in CSTL in Q3 2024 and has held it in 4 quarters since. The position peaked at $140K in Q3 2024. 173 funds tracked by Wall St. Rank hold CSTL as of Q3 2025.

  • Point72 (DIFC) held 2,386 shares of Castle Biosciences worth $54.3K as of Q3 2025.
  • Castle Biosciences was a new Point72 (DIFC) position in Q3 2025.
  • Castle Biosciences made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #708 holding.
  • Point72 (DIFC) first reported a position in Castle Biosciences in Q3 2024 and has held it in 4 quarters since.
  • Point72 (DIFC)'s Castle Biosciences position peaked at $140K in Q3 2024.
  • 173 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.